The University of Chicago Header Logo

A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer.

A Phase II Study of sEphB4-HSA in Metastatic Castration-Resistant Prostate Cancer. Clin Genitourin Cancer. 2022 12; 20(6):575-580.

View in: PubMed